Cart
sales@molnova.com
Bio-AMS
CAS No. 1393881-52-1
Bio-AMS ( —— )
Catalog No. M11642 CAS No. 1393881-52-1
Bio-AMS is a chemical inhibitor of Mycobacterium tuberculosis biotin protein ligase ( MtBPL) with Kd of 0.865 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBio-AMS
-
NoteResearch use only, not for human use.
-
Brief DescriptionBio-AMS is a chemical inhibitor of Mycobacterium tuberculosis biotin protein ligase ( MtBPL) with Kd of 0.865 nM.
-
DescriptionBio-AMS is a chemical inhibitor of Mycobacterium tuberculosis biotin protein ligase ( MtBPL) with Kd of 0.865 nM; possesses selective activity against Mycobacterium tuberculosis ( Mtb) and arrests fatty acid and lipid biosynthesis, enhances tuberculosis chemotherapy (rifampicin and ethambutol).
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1393881-52-1
-
Formula Weight571.63
-
Molecular FormulaC20H29N9O7S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5'-[ N-(d-biotinoyl)sulfamoyl]amino-5'-deoxyadenosine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tiwari D, et al. Sci Transl Med. 2018 Apr 25;10(438). pii: eaal1803.
2. Bockman MR, et al. ACS Infect Dis. 2018 Apr 17. doi: 10.1021/acsinfecdis.8b00038.
2. Bockman MR, et al. ACS Infect Dis. 2018 Apr 17. doi: 10.1021/acsinfecdis.8b00038.
molnova catalog
related products
-
GSK 951A
A small molecule with bactericidal efficacy against Mycobacterium tuberculosis with H37Rv MIC of 0.16 uM.
-
Gentamycin sulfate
Gentamycin Sulfate is a broad-spectrum, aminoglycoside antibiotic used for cell culture which inhibits protein synthesis in sensitive organisms.
-
Fosfomycin Disodium
Fosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.
